NO135892C - Fremgangsmaate til fremstilling av en lokalanestetisk virksom injeksjonsopploesning - Google Patents

Fremgangsmaate til fremstilling av en lokalanestetisk virksom injeksjonsopploesning

Info

Publication number
NO135892C
NO135892C NO4558/71A NO455871A NO135892C NO 135892 C NO135892 C NO 135892C NO 4558/71 A NO4558/71 A NO 4558/71A NO 455871 A NO455871 A NO 455871A NO 135892 C NO135892 C NO 135892C
Authority
NO
Norway
Prior art keywords
preparing
procedure
local anesthetic
injection solution
active injection
Prior art date
Application number
NO4558/71A
Other languages
English (en)
Norwegian (no)
Other versions
NO135892B (de
Inventor
Herbert John Frederick Adams
Bertil Herbert Takman
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Publication of NO135892B publication Critical patent/NO135892B/no
Publication of NO135892C publication Critical patent/NO135892C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO4558/71A 1971-01-26 1971-12-10 Fremgangsmaate til fremstilling av en lokalanestetisk virksom injeksjonsopploesning NO135892C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10994271A 1971-01-26 1971-01-26

Publications (2)

Publication Number Publication Date
NO135892B NO135892B (de) 1977-03-14
NO135892C true NO135892C (no) 1978-05-16

Family

ID=22330411

Family Applications (2)

Application Number Title Priority Date Filing Date
NO4557/71A NO135891C (no) 1971-01-26 1971-12-10 Fremgangsmaate til fremstilling av en lokalanestetisk virksom injeksjonsopploesning
NO4558/71A NO135892C (no) 1971-01-26 1971-12-10 Fremgangsmaate til fremstilling av en lokalanestetisk virksom injeksjonsopploesning

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO4557/71A NO135891C (no) 1971-01-26 1971-12-10 Fremgangsmaate til fremstilling av en lokalanestetisk virksom injeksjonsopploesning

Country Status (18)

Country Link
AT (2) AT310938B (de)
AU (1) AU465875B2 (de)
BE (2) BE776769A (de)
BR (2) BR7108429D0 (de)
CA (2) CA986012A (de)
DD (2) DD96400A5 (de)
DE (2) DE2163054C3 (de)
DK (2) DK130389B (de)
ES (2) ES398109A1 (de)
FR (2) FR2123277B1 (de)
GB (1) GB1370904A (de)
HU (2) HU162347B (de)
IE (2) IE35910B1 (de)
LU (1) LU64664A1 (de)
NL (2) NL7117404A (de)
NO (2) NO135891C (de)
SE (2) SE391127B (de)
ZA (2) ZA718326B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4917894A (en) * 1988-06-29 1990-04-17 Beecham Inc. Rapid-onset long-duration oral anesthetic composition
US6030974A (en) * 1997-04-02 2000-02-29 The Regents Of The University Of California Method of anesthesia
WO1998051290A2 (en) * 1997-05-16 1998-11-19 Children's Medical Center Corporation Local anesthetic formulations comprising a site 1 sodium channel blocker combined with a second active agent
CN103271920A (zh) 2006-03-27 2013-09-04 威克斯医药有限公司 钠通道阻滞剂治疗由于化疗而产生的神经病理性疼痛的用途
US8957207B2 (en) 2009-03-24 2015-02-17 Proteus S.A. Methods for producing phycotoxins
NZ710890A (en) 2013-03-15 2016-11-25 Childrens Medical Ct Corp Neosaxitoxin combination formulations for prolonged local anesthesia

Also Published As

Publication number Publication date
CA986012A (en) 1976-03-23
SE391127B (sv) 1977-02-07
AU3710071A (en) 1973-06-28
FR2123277B1 (de) 1975-06-13
DE2163055A1 (de) 1972-10-12
ZA718326B (en) 1972-09-27
LU64664A1 (de) 1972-08-23
HU162185B (de) 1973-01-29
NO135891B (de) 1977-03-14
IE35910L (en) 1972-07-26
IE35910B1 (en) 1976-06-23
SE391286B (sv) 1977-02-14
DK130389C (de) 1975-07-14
FR2123278A1 (de) 1972-09-08
BE776769A (fr) 1972-06-16
NL7117401A (de) 1972-07-28
NO135892B (de) 1977-03-14
DD96400A5 (de) 1973-03-20
ES398108A1 (es) 1975-03-01
DK131606C (da) 1976-01-12
CA983850A (en) 1976-02-17
DE2163054C3 (de) 1979-02-01
HU162347B (de) 1973-02-28
DE2163054A1 (de) 1974-05-02
DK131606B (da) 1975-08-11
IE35937B1 (en) 1976-07-07
BR7108428D0 (pt) 1973-06-14
NO135891C (no) 1978-05-16
NL7117404A (de) 1972-07-28
AT310938B (de) 1973-10-25
FR2123278B1 (de) 1975-08-01
DD96144A5 (de) 1973-03-12
FR2123277A1 (de) 1972-09-08
GB1370904A (en) 1974-10-16
ZA718327B (en) 1972-09-27
IE35937L (en) 1972-07-26
BE776768A (fr) 1972-06-16
AU465875B2 (en) 1975-10-09
BR7108429D0 (pt) 1973-06-14
AT310939B (de) 1973-10-25
ES398109A1 (es) 1975-03-16
DK130389B (da) 1975-02-17
AU3710171A (en) 1973-06-28
DE2163054B2 (de) 1978-06-01

Similar Documents

Publication Publication Date Title
AT339468B (de) Setznadel
DK132992C (da) Infusionskanyleaggregat
IT971014B (it) Siringa a due camere
AT354605B (de) Arzneimittelinjektor
SE390114B (sv) Forfarande for forangning av en vetska
NO145918C (no) Fremgangsmaate for fremstilling av 7-acylamido-3-cefem-4-karboksylsyrer
IT969896B (it) Procedimento per fabbricare zeaxantina
NO139486C (no) Fremgangsmaate for fremstilling av en vaskemiddelblanding
IT954825B (it) Procedimento per preparare acidi i amminoalcan i i difosfonici
SE382809B (sv) Forfarande for framstellning av fenoxiettiksyraderivat
RO76228A (ro) Procedeu pentru prepararea hidrazinei
BE784321A (fr) Moule a injecteur
NO135891C (no) Fremgangsmaate til fremstilling av en lokalanestetisk virksom injeksjonsopploesning
IT966648B (it) Supporto per iniezioni
SE384800B (sv) Lekemedelsinsprutningsanordning
SE417711B (sv) Forfarande for framstellning av 5-iminometyl-2-nitroimidazolderivat
SE391332B (sv) Forfarande for framstellning av en fenyletanolamin
NO136836C (no) Fremgangsm}te til fremstilling av hydrokinon
SE393376B (sv) Forfarande for framstellning av pyrimidinonderivat
IT964054B (it) Procedimento per preparare un gas riducente
SE386664B (sv) Forfarande for framstellning av cystinhaltiga peptider
IT961853B (it) Procedimento per produrre timolo
IT966747B (it) Procedimento per preparare dinitroantrachinoni
SE385706B (sv) Forfarande for framstellning av terapeutiskt aktiva linkomycinanaloger
SE405119B (sv) Forfarande for framstellning av 2,4-diamino-5-bensyl-pyrimidiner